SLGL
Sol-Gel Technologies Ltd. - Ordinary Shares (SLGL)
$87
About Sol-Gel Technologies Ltd. - Ordinary Shares (SLGL)
Sol-Gel Technologies Ltd. operates as a clinical-stage dermatology company, which engages in the identification, development, and commercialization of topical dermatological drug products for the treatment of skin diseases. Its products include VERED, TWIN, and SIRS-T. The company was founded by David Avnir and Alon Seri-Levy on October 28, 1997 and is headquartered in Ness Ziona, Israel.
Details
Daily high
$67.62
Daily low
$66.30
Price at open
$67.42
52 Week High
$97.97
52 Week Low
$23.15
Market cap
218.7M
Dividend yield
-
Volume
5,652
Avg. volume
68,879
P/E ratio
-11.83
Sol-Gel Technologies Ltd. - Ordinary Shares News
Details
Daily high
$67.62
Daily low
$66.30
Price at open
$67.42
52 Week High
$97.97
52 Week Low
$23.15
Market cap
218.7M
Dividend yield
-
Volume
5,652
Avg. volume
68,879
P/E ratio
-11.83